Allied Minds Backs Precision Biopsy With $2.5M
Precision Biopsy has closed on $2.5 million from Allied Minds. The funding will help the company with the commercialization phase of its novel prostate cancer detection technology. Precision Biopsy was formed Allied Minds in cooperation with the University of Colorado. Allied Minds is a private equity-funded innovation company with offices in Boston and Los Angeles.
6 July 2011•2 mins read
